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SUMMARY 26 
Our findings imply that simple functional tests can predict both hip fracture risk and excess 27 
mortality in postmenopausal women. Since the tests characterize general functional capacity (one-28 
legged stance, squatting down and grip strength), these simple measures should have clinical utility 29 
in the assessment of women at risk of falls and fragility fracture. 30 
 31 
ABSTRACT 32 
Introduction 33 
Functional impairment is associated with the risk of fall, which is the leading cause of hip fracture. 34 
We aimed to determine how clinical assessments of functional impairment predict long-term hip 35 
fracture and mortality.  36 
Methods 37 
A population based prospective cohort involved 2815 Caucasian women with the average baseline 38 
age of 59.1 years. The mean follow-up time in 1994-2014 was 18.3years. Three functional tests and 39 
their combinations assessed at baseline were treated as dichotomous risk factors; 1) inability to 40 
squat down and touch the floor (SQ), 2) inability to stand on one leg for ten seconds (SOL) and 3) 41 
having grip strength (GS) within the lowest quartile (≤58 kPa, mean 45.6kPa). Bone mineral density 42 
(BMD) at the proximal femur was measured by DXA. Fractures and deaths were verified from 43 
registries. Hazard ratios were determined by using Cox proportional models. Age, body mass index 44 
(BMI) and BMD were included as covariates for fracture risk estimates. Age, BMI and smoking 45 
were used for mortality. 46 
Results 47 
Altogether 650 (23.1%) women had 718 follow-up fractures, including 86 hip fractures. The 48 
mortality during the follow-up was 16.8% (n=473). Half of the women (56.8%, n=1600) had none 49 
of the impairments and were regarded as the referent group. Overall, women with any of the three 50 
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impairments (43.2%, n=1215) had higher risks of any fracture, hip fracture and death, with hazard 51 
ratios (HR) of 1.3 ((95% CI) 1.0-1.5, p<0.01), 2.4 (1.5-3.4, p<0.001), 1.5 (1.3-1.8, p<0.001), 52 
respectively. The strongest single predictor for hip fracture was failing to achieve a one-leg stand 53 
for ten seconds (Prevalence 7.1%, n=200), followed by inability to squat down (27.0%, n=759) and 54 
weak grip strength (24.4%, n=688), with their respective HRs of 4.3 (2.3-8.0, p<0.001), 3.1 (2.0-55 
5.0, p<0.001) and 2.0 (1.2-3.4, p<0.001). In addition, age, lower BMD, BMI and smoking were 56 
significant covariates. 57 
Conclusions 58 
These findings suggest that functional tests provide long-term prediction of fracture and death in 59 
postmenopausal women. Whether reversal of these impairments is associated with a reduction in 60 
adverse outcomes, is an area for future trials. 61 
 62 
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INTRODUCTION 65 
Hip fractures among the elderly often result in disability, loss of independence, high societal costs 66 
and death (1,2). On the other hand, low muscle strength and functional impairment have commonly 67 
been present already before hip fracture (3-7). In fact, more than 90% of hip fractures occur because 68 
of a fall (8), typically in sedentary and frail persons (9) with low bone mass (10). It is known that 69 
poor physical function and low level of physical activity are associated with an elevated risk for 70 
fractures and death in the elderly (11,12). However, the use of simple functional tests for prediction of 71 
hip fracture and death in postmenopausal women before old age has not been established in long 72 
term prospective settings.  73 
 74 
While low femoral bone mineral density (BMD) is a risk factor for hip fracture (13), the majority of 75 
hip fractures occur in patients with ’normal’ or ’osteopenic’ BMD values. This makes population-76 
based screening of osteoporosis using densitometry alone a non-optimal solution and is not 77 
recommended (14). Although BMD variation on global scale does not reflect the expected incidence 78 
of hip fracture (15), profiling with risk factor tools (such as FRAX) and BMD is a clinically effective 79 
approach for preventing hip fracture and is a widely accepted strategy, at least in the over 75 age 80 
group. Currently, common fracture risk tools do not take into account the risk that arises from 81 
functional impairment, which usually arises due to other health disorders (16). As multiple factors 82 
contribute to the hip fracture risk, combining BMD with other factors may improve the assessment 83 
of fracture risk in clinical use (17,18).  84 
 85 
Fall-related injury and fracture rates increase steeply with age. Hip fracture rates present one of the 86 
most dramatic changes with a rise of 100 to 1000-fold in the elderly over 60 years of ageing (19). 87 
Poor balance, low muscle strength and impaired coordination are associated with frequent falling in 88 
frail nursing elderly (20). Thus, the preservation of functional capability is of utmost importance in 89 
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preventing falls (21,22). Crucially, the factors determining physical function remain modifiable even 90 
in old age (23).   91 
Altogether, there are few prospective cohort studies examining the functional status of 92 
postmenopausal women and how such functional measures relate to BMD and register-based 93 
outcomes in a long-term follow-up setting. Therefore, research is needed to quantify the role of 94 
functional status and its decline in the prediction of fracture and death. This would help in 95 
identification of women who are most likely to benefit from exercise intervention. 96 
We have previously shown an association between fracture risk and functional status in 97 
postmenopausal women (24). In addition to self-reported fractures, the current study focuses on 98 
health registry data with hip fractures and mortality. Since we have carefully assessed baseline 99 
functional impairment in women subsequently followed-up for a long time, we are now able to 100 
characterize the relationships between their task performance and key health outcomes in later old 101 
age. 102 
Our objective was to investigate the ability of clinically applicable functional tests to predict 103 
fracture risk and mortality among postmenopausal women in a long-term prospective cohort study. 104 
 105 
MATERIALS AND METHODS 106 
Study design 107 
The study population consisted of the ongoing Kuopio Osteoporosis Risk Factor and Prevention 108 
(OSTPRE) Study cohort. This population based long-term follow-up study includes all the 14 220 109 
Finnish women aged 47 to 56 years who lived in the Kuopio Province, Eastern Finland, in April 110 
1989. A postal questionnaire was mailed to 14 120 of these women at baseline 1989 with a response 111 
rate of 13 100 (92.8%). The follow-up questionnaire was mailed in 1994, 1999, 2004, 2009 and in 112 
2014 to women who responded to the baseline enquiry and were alive at the time, respectively. The 113 
response rate varied between 80% and 93% throughout the study. The study has been approved by 114 
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the Kuopio university hospital ethics committee in 28.10.1986 and is performed in accordance with 115 
the ethical standards by the Declaration of Helsinki. Oral and written information have been 116 
provided before the onset of data collection. 117 
 118 
 119 
 120 
Bone mineral density measurement  121 
In addition to the enquiry follow-up, baseline responders were asked about their willingness to 122 
participate in bone densitometry (DXA) measurement. Altogether 11055 responders stated their 123 
willingness, which formed a pool for stratified random sample of 3686 women invited to the 124 
measurements. Out of these, 3222 women underwent the baseline DXA scan. This sample consisted 125 
of a random population sample (n=2025) and 100% samples (n=1197) of women with higher risk 126 
profiles: menopause within 2 years (n=857), diseases or medication affecting bone (n=245) and 127 
multiple behavioral risk factors (n=95) (25). The baseline sample (n=3222) has been followed with 128 
bone densitometry and clinical measurements at five-year intervals since 1989. The detailed 129 
description of DXA follow-up protocol has been published previously (26).  130 
 131 
Clinical measurements 132 
At the 5th year follow-up visit (in 1994-8) additional functional capacity measurements were 133 
introduced to the OSTPRE follow-up clinical measurements protocol, including grip strength, 134 
ability to stand on one leg for ten seconds (SOL) and ability to squat down and touch the floor (SQ). 135 
Thus, in the current study, these 5th year follow up measurements were set as the baseline for this 136 
study. Altogether, the final sample of this study included 2815 women with valid baseline 137 
measurements of functional capacity, femoral neck bone densitometry (DPX-IQ, Madison, WI, 138 
USA) and postal enquiry data. Anthropometric measurements (height and weight) were recorded in 139 
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light clothing without shoes, using calibrated weight scale and stadiometer. Body mass index (BMI) 140 
was calculated as weight (kilogram)/height (meter) squared. Femoral neck BMD was expressed as 141 
T-scores calculated using young Finnish female normative values. 142 
All three functional tests were treated as dichotomous outcomes (no / yes). These included maximal 143 
grip strength result ranking in the weakest (≤58 kPa) quartile (mean 45.6kPa, median 50.0kPa), 144 
inability to squat down while touching the floor with fingertips and getting up without assistance 145 
(without using support or being assisted)  and inability to stand on one leg for ten seconds while 146 
resting hands on the hip. Any underlying medical conditions contributing to failure in functional 147 
tests were not diagnosed or classified on site. Grip strength was measured three times with a hand-148 
held pneumatic squeeze dynamometer (Martin Vigorimeter; Medizin-Technik, Tuttlingen, 149 
Germany) from the dominant hand. Maximum strength was determined by calculating the mean 150 
value of the best two (out of three) attempts and results were divided into quartiles. Reproducibility 151 
of this method is considered reliable based on the intra-class correlation coefficient (ICC) of the 152 
grip strength measurement previously reported to be 0.87–0.97 for absolute values (27). The women 153 
without any of the three functional impairments (no failed tests or in the lowest grip strength tertile) 154 
were treated as a referent category (n=1600).  155 
 156 
Covariates 157 
Covariates of interest such as current smoking, alcohol consumption, duration of hormone therapy 158 
(HT) use and menopausal status were recorded from the baseline inquiry. Women were considered 159 
menopausal after 12 months of amenorrhea. Smoking was questioned as average cigarette 160 
consumption per day and treated as a dichotomous variable of any current smoking (smoker / non-161 
smoker). 162 
 163 
Fractures and deaths 164 
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Fractures were classified in two mutually non-exclusive outcomes as any fracture and hip fracture. 165 
The hip fractures of the cohort were verified using the nationwide Hospital Discharge Register data 166 
(HILMO) as well as by postal enquiries sent to the participants (at 5, 10, 15, 20 and 25 follow-up 167 
years). All self-reported fractures during the years 1987–2014 were validated by patient perusals 168 
and hospital records. Information of circumstances contributing to fracture was not available.  169 
Seasonal distribution of fractures between groups was compared.  The relevant International 170 
Classification of Diseases (ICD) codes were used to include femoral neck, pertrochanteric and 171 
subtrochanteric fractures (ICD-10:  S72.0 – S72.2). Women with a hip fracture prior to the baseline 172 
visit, pathologic and periprosthetic hip fractures were excluded (n=12). We have previously shown 173 
that the observed number of hip fractures from the register data was significantly higher than the 174 
self-reported one. The patients with no response to postal inquiries had significantly higher hip 175 
fracture risk. Thus, relying on self-reports only would have resulted biased incidence, and period 176 
prevalence estimates. Altogether, self-reports missed to capture 38 % of hip fractures in this long-177 
term follow-up cohort (28). 178 
Time and cause of death were obtained until the end of 2014 according to the national adaptation of 179 
the International Statistical Classification of Diseases, Injuries and Causes of Death (ICD) from the 180 
National Causes of Death Register. The death certification practice and cause of death register have 181 
previously shown to be very accurate 29. Correspondingly, follow-up of the hip fracture risk analysis 182 
was stopped to the end of 2014.  183 
 184 
Statistical analyses  185 
The 5th year follow up visit date (including DXA, anthropometric data and functional tests) of the 186 
OSTPRE study was regarded as the baseline for the analysis. Depending on the event of interest, 187 
follow-up was terminated to the day of death, first fracture, first hip fracture, at the end of the 188 
registry period or last returned questionnaire date during follow up (overall fracture analysis, based 189 
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on self-reports). Overall fracture risk, hip fracture risk and mortality were estimated with a time 190 
scale of years from baseline by using survival analyses; Kaplan-Meier curves for unadjusted and 191 
Cox proportional hazards regression model for adjusted analyses, with a mean (median) follow-up 192 
time of 13.8 (17.0) years, 17.4 (18.2) years and 17.6 (18.3) years, respectively. In193 
 194 
survival analyses cases were censored at their date of death.  Mortality did not appear to have 195 
significant effect on fracture risk results as a competing outcome. Cox multivariable proportional 196 
hazards regression model was used with other baseline covariates of interest, including femoral 197 
neck (FN) BDM, grip strength (kPa), functional capacity (SQ, SOL), age, height, weight, history of 198 
HT use (years), amount of physical activity (hours per week) and dietary calcium intake (mg/day). 199 
Other potential variables including duration of HT use, dietary calcium intake and amount of self-200 
reported physical activity were excluded from the final Cox model. Both physical activity and HT 201 
use associated with better functional capacity and lower BMI, while neither had significant impact 202 
on adjusted fracture or mortality hazard models (data not shown). Proportional hazards assumptions 203 
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between study groups were tested based on Schoenfeld residuals, while no significant variations 204 
were detected. Hazard ratios have been reported with their respective 95% CI. Potential non-205 
linearity of continuous covariates (Age, T-Score, BMI) was assessed with the squared terms in the 206 
model. Slight correlation was detected between BMI and T-Score (r=0.39, p<0.001), while the data 207 
met the assumption that multicollinearity was not a concern (Tolerance = .85, VIF = 1.18; T-Score, 208 
Tolerance = .85, VIF = 1.18) and both were included in the analysis. The random sample of the 209 
study population (n=2025) was extracted prior to the extraction of 100% sample including high-risk 210 
sample stratification for clinical measurements follow-up. No differences were detected between the 211 
stratified and random sample BMD values (T-Test, p=0.9).  The area under the receiver operating 212 
characteristic curve (AUC) and the corresponding confidence intervals (CIs) were calculated to 213 
estimate functional impairment status (y/n), age (years) and BMD (T-Score) predict the main 214 
outcomes of hip fracture and any fracture. Statistical analysis were conducted with SPSS version 215 
23. 216 
 217 
 218 
RESULTS 219 
Characteristics 220 
The cohort consisted of 2815 women with a mean baseline age of 59.1 years (SD 2.9, range 53 – 221 
66) and with valid measurement results (table 1). According to the self-report, 93% of the women 222 
were postmenopausal at baseline. Half of the women (50.6%) reported HT use in the preceding five 223 
years, with the mean duration of 1.8 years. The qualifying percentages with squatting down to floor 224 
and stand on one leg for ten seconds were 73 % and 92.9 %, respectively. 225 
 226 
See table 1. 227 
 228 
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 229 
Fracture incidence and all-cause mortality 230 
Altogether 650 (23.1%) women reported 718 fractures during the follow-up. Wrist (n=279, 38.9%) 231 
and ankle (n=118, 16.4%) were the most common sites of fractures. Women with functional 232 
impairment had a higher overall fracture risk (Figure 1).  Only hip fracture showed an exclusive 233 
type specific association with functional impairment (Figure 2). The majority (77.3 %) of all 234 
fractures occurred during winter (Nov-Apr). The referent group had higher seasonal variation in the 235 
overall fracture incidence: the majority of their fractures (86.0 %) occurred during winter, compared 236 
to the functional impairment (68.3%, p<0.01) group whose fractures were spread over the seasons. 237 
A total of 86 women sustained a hip fracture during the follow-up, without any seasonal variation. 238 
The crude hip fracture incidence per 100 000 person-years among referent and functional 239 
impairment groups were 113 ((95% CI) 93.1-135.9) and 261 (230.3-294.7), respectively (Figure 2). 240 
 241 
 242 
See figure and legend 1. (ANY FRACTURE by TIME).  243 
 244 
See figure and legend 2. (HIP FRACTURE by TIME).  245 
 246 
The all-cause mortality during the follow-up was 16.8% (n=473). A higher death rate was observed 247 
in women with functional impairment compared to the referents with mortality of 20.4% and 248 
14.1%, respectively (Log-rank p˂ 0.001) (Figure 3.). Examing each functional impairment, the 249 
highest death rate was observed in those that could not perform the single-leg stand (SOL), 250 
followed by those with low grip strength (GS) and finally those that could not squat (SQ), with 251 
overall mortality of 30.5%, 22.7% and 21.3%, respectively.  The most common causes of death 252 
(ICD-10) were atherosclerotic heart disease (I251) (8.9%), breast cancer (C504) (3.4%), ovarian 253 
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cancer (C56) (2.5%), and Alzheimer's disease (G301) (2.3%). In the adjusted Cox model, baseline 254 
smoking (y/n), age (years) and functional impairment (any vs. none) remained independent 255 
predictors of death with respective HRs of 2.1 (1.6-2.7, p<0.001), 1.1 (1.0 – 1.1, p=0.001), 1.4 (1.1-256 
1.6). 257 
 258 
See figure and legend 3. (MORTALITY by TIME). 259 
 260 
The final Cox multivariable fracture risk models including any functional impairment were adjusted 261 
for age, BMI and BMD T-score, which all remained significant covariates for hip fracture with a 262 
HRs of 1.2 (1.1-1.3, p<0.01), 1.1 (1.0-1.1, p<0.01) and 2.5 (1.9-3.2, p<0.001) per each unit of 263 
change, respectively. In multivariate fracture risk estimates age did not appear as independent risk 264 
factor for any fracture with HRs of 1.02 (0.99-1.05, p=0.3), 1.02 (1.0-1.04, p=0.03) and 1.5 (1.3-265 
1.6, p<0.001) for age, BMI and BMD, respectively. Prevalence for any functional impairment in 266 
stratified high-risk sample and random sample were 45.6% and 41.8%, respectively, with a 267 
borderline significance (Chi-square p= 0.050).  However, adjusted hip fracture risk estimates for 268 
any impairment in random sample were approximately the same (HR 1.9, 1.0-3.3) than in total 269 
sample results (HR1.7, 1.0-2.6). 270 
The AUC was used to evaluate the goodness of functional impairment (any), age (years) and BMD 271 
(T-Score) in the detection of fractures. In univariate model, all three risk factors appeared 272 
significant (p<0.05) indicators of hip fracture, with AUC (CI95%) of 0.60 (0.54-0.66), 0.67 (0.61-273 
0.73), and 0.70 (0.65-0.75), respectively. In hip fracture multivariable model with BMI and age, 274 
AUC (Mean (CI95%)) estimate was 0.67 (0.62-0.73). Adding functional test status, BMD or both 275 
risk factors simultaneously in the model, the estimates were 0.70 (0.65-0.75), 0.77 (0.73-0.81) and 276 
0.78 (0.74-0.82), respectively. For any fracture as an outcome, the base multivariable model AUC 277 
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estimate with BMI and age was 0.53 (0.51-0.56). By adding functional test status, BMD or both in 278 
the model, the estimates were 0.54 (0.52-0.57), 0.60 (0.58-063) and 0.60 (0.58-0.63), respectively. 279 
 280 
See table 2. 281 
 282 
Bone mineral density 283 
No difference was seen in femoral neck BMD (g/cm2) or T-Score value between functional 284 
impairment and healthy referent groups (Table 1). The overall number of osteoporotic (T-Score ≤ -285 
2.5) women at the baseline was low (2.5%, n=69). Among the functional impairments, only women 286 
belonging to the lowest grip strength tertile had significantly lower (2.7%) baseline BMD value 287 
than the referent group (p<0.001).  288 
The relative bone loss rate in the available 15 year DXA follow-up subsample (n=1401) was higher 289 
among the functional impairment group (n=516) than in the referents (n=885), with -6.1% (SD 8.2) 290 
and -4.9% (7.4) bone loss rates, respectively (p<0.01). However, at the latest 20 year DXA follow-291 
up measurement (n=762) no difference between the impairment (n=251) and the referent (n=511) 292 
groups was observed, with final bone loss rates of -6.7% (9.4) and -6.0% (8.9), respectively (p=0.3). 293 
Overall, the cox multivariable showed 2.5x elevation for hip fracture hazard per SD lower BMD 294 
which put this study in alignment with previous literature. 295 
 296 
Functional tests 297 
Altogether, around one third (n=959, 34.1%) of the women had at least one failure in functional 298 
tests (SOL, SQ). The most common disability was squatting down, touching the floor and getting 299 
up without assistance (n=759, 27.0%). Significantly fewer women failed the one leg stand for 10 300 
seconds (n=200, 7.1%).  In addition, weaker grip strength was observed among women with failed 301 
SOL and SQ compared to referent group, with mean grip strength of 70.0 kPa, 55.9 kPa and 302 
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77.1kPa respectively (p<0.001). All functional assessments and their combinations with respective 303 
prevalence (n, %) are presented in table 2  304 
 305 
DISCUSSION 306 
 307 
This study showed that simple functional tests (low grip strength, inabilities to squat down or stand 308 
on one leg) not only predicted hip fracture well, but also predicted mortality in postmenopausal 309 
women. The study also confirmed the multifactorial nature of hip fracture, where age, BMD, and 310 
functional status are all significant and independent contributors to the risk. 311 
 312 
Previously, several life style factors have been identified as predictors for falls, fractures and bone 313 
loss in the elderly (30-32). Prior to our work, it had not been conclusively shown that functional tests  314 
were long-term predictors of postmenopausal fractures and mortality.  Functional measurement, 315 
such as grip strength, are commonly used tools for the assessment of physical condition. The have 316 
been shown to have prognostic value for a variety of health outcomes throughout the population, 317 
regardless of age, gender or socioeconomic background 33-35. However, due to strong multifactorial 318 
and overlapping effects, infrequent outcomes such as hip fracture are challenging to predict. Even a 319 
single potential indicator such as BMD provides a more optimal approach whenever DXA imaging 320 
can be combined with clinical risk factors, thus resulting in higher specificity and sensitivity than 321 
either alone (36).  322 
 323 
 324 
Confounding may always be present in observational studies, although no specific medical 325 
conditions affecting the functional test results were detected. The hip fractures of the cohort 326 
obtained from the nationwide Hospital Discharge Register are known to be accurate figures (28,37). 327 
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Other fracture information (excluding hip) was based on follow-up self-reports which were 328 
validated by using medical records. Self-reporting has previously shown to be a relatively reliable 329 
way to obtain information about past major fractures in OSTPRE cohort, where 84% proved to be 330 
true fractures (38). Although the absolute number of fractures is likely to be an underestimate, we 331 
don’t believe that self-reporting would have limited the reliability of the main results. Selection 332 
specific limitation, such as systematic underreporting of fractures among the impairment groups 333 
cannot be totally excluded. However, if women in impaired groups reported fractures with lower 334 
reliability than others, the potential bias would be conservative rather than an overestimate of 335 
events.  Despite the validated outcome events based on self-reports and register data including hip 336 
fractures and mortality, our study was of observational nature without record on actual course of 337 
events and circumstances leading to fracture. A clear majority of fractures occurred during winter 338 
(November to April), matching with the period when local temperature remains below zero degrees 339 
Celsius (Data not shown). During winter, the referent group had higher incidence of fractures, 340 
which suggests a stronger association to seasonal weather conditions (26). However, this variation 341 
did not apply to hip fracture, suggesting a stronger relationship with functional capacity rather than 342 
outdoor exposure. Although outdoor activities may have exposed to falls, the main associations 343 
between physical impairment and subsequent hip fracture risk were clear (Figure 4). Falls combined 344 
with low BMD are a common cause for frailty related fractures and a considerable cause for 345 
medical expenditure of non-fatal injuries (39,40). In this study, a reasonable number of hip fractures 346 
during the very long follow up period also provides a meaningful risk estimation and enables 347 
comparison between types of functional impairment. However, the number of women with different 348 
combinations of impairment remained small for conclusive risk estimates. After adjusting for BMD, 349 
these results showed that the added value of combinations of impairment for fracture prediction was 350 
relatively low. While baseline BMD did not have difference between groups, its contribution to 351 
fracture risk estimates remained the most significant factor in all models.  352 
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 353 
 354 
See figure and legend 4 (RISKFACTORS).  355 
 356 
 357 
The strength of this study was a large population-based cohort of Caucasian women with a long 358 
follow-up time combined with clinical measurements and validated registry outcomes for hip 359 
fractures and mortality. The cohort presents a homogenous sample of postmenopausal women 360 
before old age with relatively narrow age range. The study demonstrated a set of quantifiable 361 
physical tasks, which can be regarded as a threshold for generic functional capacity needed in 362 
everyday life. The simplicity of the tests suggest that they should have clinical utility for screening 363 
and risk evaluation of frailty related health outcomes, but more studies are needed to determinate 364 
their true clinical value. The finding that elevated risk was detected relatively early after menopause 365 
and well before accumulation of fractures, combined with the fact that physical functioning is 366 
modifiable, make these findings appealing. The inability to stand on one foot for ten seconds had 367 
the smallest failure rate but the highest predictive hazard ratio for any of the outcomes.  The 368 
unilateral posture demands hip, core and leg muscles to compensate accordingly with the 369 
proprioceptive system to provide additional support for the body. Standing on one foot provides a 370 
constant challenge on both of these properties, muscle coordination and balance, which might 371 
explain the highest risk prediction.  372 
 373 
Tests like timed up and go or gait speed have previously shown evidence for long-term prediction 374 
of falls, fractures and survival in the elderly (41-43). It has been suggested that BMD contributes less 375 
to fracture risk when another strong risk factor, such as frequent falling, is present (44). A similar 376 
association between clinical balance measures and FRAX® have also been demonstrated, 377 
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suggesting that functional tests could bring additional value for fracture risk estimates (45). To study 378 
the improvement of risk estimate we would have needed statistical model of FRAX®, which is 379 
currently inaccessible for integration of risk factors such as functional tests. However, the results 380 
indicate a need for further studies with functional tests that can be done without additional devices 381 
to determine if there is improved fracture prediction. 382 
 383 
In conclusion, the simple functional tests described here predict hip fracture, overall fracture risk 384 
and mortality among postmenopausal women. The tests have potential for clinical application, by 385 
assessing the degree of functional impairment and subsequent hip fracture risk, well before the 386 
onset of actual injuries. Furthermore, performance in these tasks can provide meaningful and 387 
tangible goals for an individual or for societal public health programs involving rehabilitation. 388 
However, pragmatic clinical trials are needed to evaluate how reversal of these functional deficits 389 
would be associated with the reduction of adverse health outcomes.  390 
 391 
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FIGURES and LEGENDS  528 
Figure 1: Kaplan-Meier survival curves for functional impairment (red) and referent (green) groups 529 
on cumulative hazards for any fracture by time (Years) (Log rank, p<0.01) with incidence of 23.1% 530 
(n=650) during the follow up. 531 
 532 
  533 
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Figure 2: Kaplan-Meier survival curves for functional impairment (red) and referent (green) groups 534 
on cumulative hazards for hip fracture by time (Years) (Log rank, p<0.001) with incidence of 3.1% 535 
(n=86) during the follow up. 536 
 537 
  538 
25 
 
Figure 3: Kaplan-Meier survival curves for functional impairment (red) and referent (green) groups 539 
on cumulative hazards for mortality by time (Years) (Log rank, p<0.001) with incidence of 16.8% 540 
(n=473) during the follow up. 541 
 542 
  543 
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Figure 4: Cumulative effect of different functional impairments on hip fracture risk (Adopted from 544 
table 2.). For complete set of hazard ratios with functional impairment combinations and outcomes 545 
of interest see table 2. 546 
 547 
 548 
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TABLES 550 
Table 1. Baseline characteristics of the total study population (n=2815), referent group and functional 551 
impairment group with their respective mean (SD) or proportions. 552 
Characteristic Total  
(N=2815) 
Referent group 
(n=1600) 
Functional 
impairment group 
(n=1215) 
p valuea 
Age, y  59.1 (2.9) 58.7 (2.8) 59.6 (2.9) <0.001 
Height, cm 160.0 (5.7) 160.5 (5.2) 159.3 (5.8) <0.001 
Weight, kg  71.9 (12.9) 70.0 (11.1) 74.5 (14.5) <0.001 
Body mass index 28.1 (4.9) 27.2 (4.2) 29.3 (5.4) <0.001 
Grip strength, kPa 68.8 (18.1) 77.1 (12.9) 57.8 (18.0) <0.001 
Unable to squat down and 
get up, % 
27.0 0 27.062.5 <0.001 
Unable to stand on one 
foot for 10 sec, % 
7.1 0 7.116.4 <0.001 
Current smoker, % 9.0 8.6 9.5 ns 
Alcohol consumption, 
g/month 
56.7 (116.3) 60.2 (108.5) 52.0 (125.7) ns 
Postmenopausal, % 93.1 91.2 95.7 <0.001 
Duration of HT during 
previous 5 years, y 
1.8 (2.3) 2.0 (2.4) 1.5 (2.2) <0.001 
Physical activity, h/week 4.2 (6.5) 4.5 (6.5) 3.8 (6.6) <0.01 
Femoral neck BMD, g/cm2 0.900 (0.127) 0.902 (0.124) 0.898 (0.130) ns 
Femoral neck BMD,  
T-Score 
-0.66 -0.65 -0.68 ns 
Bone loss in 15 years, %  b -5.3 (7.7) -4.9 (7.4) -6.1 (8.2) <0.01 
Bone loss in 20 years, %  c -6.3 (9.0) -6.0 (8.9) -6.7 (9.4) 0.3 
a Difference between functional impairment (any) and referent group (t-test and Chi-square test) 553 
b Subsample of 1401 women with available 15 year DXA follow-up data, among referent (n=885) 554 
and functional impairment (n=516) groups. 555 
c Subsample of 762 women with available 20 year DXA follow-up data, among referent (n=511) 556 
and functional impairment (n=251) groups. 557 
28 
 
 558 
Table 2. Functional impairments with their respective prevalence (n, %) and hazard ratios (95% 559 
CIs) for mortality and fractures in comparison to the referent (n=1600). Crude and adjusted HRs are 560 
shown. Non-significant p-values (p>0.05) are indicated with ns. All other p-values are significant 561 
(p<0.01) for crude models and (p<0.05) for adjusted (a,b) models.  562 
Single impairment Prevalence  Mortality
 Mortalitya Hip fracture Hip fractureb Any fracture Any fractureb 
1. Unable to squat  
and touch the floor 
759 (27.0%) 1.6 (1.3-2.0) 1.3 (1.1-1.7)  3.1 (2.0-5.0) 2.3 (1.4-3.7) 1.2 (1.0-1.5) 1.2 (1.0-1.5) ns 
2. Unable to stand  
on one foot 10 s 
200 (7.1%) 2.5 (1.9-3.4) 1.4 (1.5-2.6) 4.3 (2.3-8.0) 2.5 (1.2-5.2) 1.6 (1.2-2.2) 1.6 (1.2-2.2) 
3. Lowest grip  
strength tertile (kPa) 
688 (24.4%) 1.7 (1.4-2.1) 1.5 (1.2-1.9) 2.0 (1.2-3.4) 1.3 (0.8-2.3) ns 1.3 (1.0-1.5) 1.1 (0.9-1.4) ns 
4. Any of the three  1215 (43.2%) 1.5 (1.3-1.8) 1.4 (1.1-1.6) 2.4 (1.5-3.4) 1.7 (1.0-2.6) 1.3 (1.1-1.5) 1.2 (1.0-1.4) 
Combination  
of impairments 
       
5. Squat +  
one foot stand 
145 (5.2%) 3.2 (2.4-4.3) 2.3 (1.7-3.3) 5.9 (3.1-11.2) 3.2 (1.5-7.0) 1.6 (1.1-2.2) 1.5 (1.0-2.1) 
6. Squat +  
low grip strength 
269 (9.6%) 2.2 (1.7-2.9) 1.9 (1.4-2.4) 3.5 (1.9-6.4) 2.0 (1.0-3.9)  1.2 (0.9-1.5) ns 1.0 (0.8-1.4) ns 
7. One foot stand +  
low grip strength 
97 (3.4%) 2.8 (2.0-4.1) 2.1 (1.5-3.2) 4.6 (2.0-10.4) 1.9 (0.7-5.0) ns 1.6 (1.0-2.4) 1.4 (0.9-2.2) ns 
8. All three 79 (2.8%) 3.4 (2.3-4.9) 2.6 (1.7-3.8) 5.9 (2.6-13.5) 2.4 (0.9-6.5)
 ns 1.5 (1.0-2.4) ns 1.4 (0.8-2.2) ns 
a adjusted for; Age, BMI, baseline smoking status (y/n) 563 
b adjusted for; Age, BMI, BMD (T-Score) 564 
ns Non significant (p>0.05) 565 
